NanoGhost

Company Overview

Snapshot

Founded in August 2019 by Prof. Marcel Machluf, NanoGhost operates with 11–50 employees. The company has secured $9 million in total capital across two funding rounds from aMoon Fund and New Gate Capital. In June 2023, NanoGhost received follow-on funding from New Gate Capital.

Business overview

NanoGhost is a Health Tech & Life Sciences company developing a drug-delivery technology that utilizes adult stem cells to precisely transport medicine to tumor sites. Its core technology is based on nano-vesicles, termed Nano-Ghosts (NGs), which are reconstructed from the cell membranes of naturally targeted allogeneic mesenchymal stem cells (MSCs). This platform aims to retain the MSCs' inherent tolerability and targeting capabilities for inflamed and malignant tissues, serving the pharmaceutical and biotechnology sectors by offering a novel approach to cancer treatment.

Strategic signal

In November 2021, NanoGhost's technology was highlighted for its potential to significantly reduce cancer drug dosages. This indicates a strong validation of the company's innovative approach to drug delivery, suggesting a future where cancer treatments could be more effective with fewer side effects, thereby enhancing patient outcomes and potentially disrupting traditional oncology treatment paradigms.

Company Intelligence Q&A

What is NanoGhost's primary technology?

NanoGhost develops a drug-delivery platform using nano-vesicles, called Nano-Ghosts (NGs), which are reconstructed from the cell membranes of naturally targeted allogeneic mesenchymal stem cells (MSCs) to deliver medicine directly to tumor sites.

When was NanoGhost founded and by whom?

NanoGhost was founded in August 2019 by Prof. Marcel Machluf, who is also the inventor of the technology.

What significant recognition has NanoGhost received?

Israel's Ministry of Science and Technology named NanoGhost as one of the country's 60 most impactful developments, recognizing its innovative drug delivery technology.

Has NanoGhost's technology been patented?

Yes, the NanoGhost technology has been patented in the United States and Europe, with additional patents pending in India and China.